Scott R. Silverman, Chairman and Chief Executive Officer of VeriChip, said, “I am very pleased with the robust growth of our infant protection and wander prevention systems. I am also proud of our focus on performance and delivering results above expectations. Looking back at 2007, VeriChip met or exceeded every qualitative and quantitative measure it established, including the number of hospitals enrolled in our VeriMed™ Patient Identification System and the number of protocol-adopted facilities.”

About VeriChip

VeriChip Corporation, headquartered in Delray Beach, Florida, develops, markets and sells radio frequency identification, or RFID, systems used to identify, locate and protect people and assets. VeriChip's goal is to become the leading provider of RFID systems for people in the healthcare industry. The Company recently began marketing its VeriMed^(TM) Patient Identification System, a passive RFID system for rapidly and accurately identifying people who arrive in an emergency room and are unable to communicate. This system uses the first human-implantable passive RFID microchip, the implantable VeriChip^(TM), cleared for medical use in October 2004 by the United States Food and Drug Administration.